Dr. Dorigo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Obstetrics and Gynecology, 1996 - 1999
- Ruprecht Karl University Faculty of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1997 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
- Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer Start of enrollment: 2020 Mar 30
Publications & Presentations
PubMed
- 731 citationsCD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapyAmira A. Barkal, Rachel E. Brewer, Maxim Markovic, Mark Kowarsky, Sammy A. Barkal
Nature. 2019-07-31 - 59 citationsQuantitative Super-Resolution Microscopy of the Mammalian Glycocalyx.Leonhard Möckl, Kayvon Pedram, Anish R. Roy, Venkatesh Krishnan, Anna-Karin Gustavsson
Developmental Cell. 2019-07-01 - 41 citationsScreening cell mechanotype by parallel microfiltrationDongping Qi, Navjot Kaur Gill, Chintda Santiskulvong, Joshua Sifuentes, Oliver Dorigo
Scientific Reports. 2015-12-02
Lectures
- To Infinity and Beyond: The Future of Immunotherapy in Gynecologic MalignanciesASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- Clinical data from the DeCidE1 trial: Assessing the first combination of DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with s...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
- Some Experts Say More Women Should Consider Removing Fallopian Tubes to Reduce Cancer RiskMarch 3rd, 2023
- Women at High Risk of Ovarian Cancer Should Consider Fallopian Tube Removal, Experts SayMarch 3rd, 2023
- Ovarian Cancer: Can Removing Fallopian Tubes Decrease the Risk?February 3rd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: